Peptest will be presented at a key European conference on digestive diseases in Italy this month.
The 24th Italian Society of Digestive Diseases Congress (FISMAD 2018) takes place in Rome on 21 to 24 March 2018 at the Ergife Palace Hotel.
One of the primary objectives of FISMAD is to create collaborations between the different scientific societies involved in the management of digestive diseases.
Organisers say this year’s Congress will feature ‘insightful and innovative talks and presentations’ on new diagnostic and treatment techniques.
A study by the Gemelli University Hospital, which looks at the use of Peptest with patients admitted for chest pain in emergency departments, will be presented by Dr Veronica Ojetti in the Poster Area of the Congress on 23 March from 12:45 to 13.30.
Peptest detects pepsin — the stomach enzyme that indicates reflux — in a saliva sample. Developed by the late Professor Peter Dettmar and used in over 40 countries, it is available directly to patients as well as NHS and private clinics.
- CE-IVD certified
- ISO 13485 manufacture
- Validated in 1,033-patient UK study
- Used in NHS voice clinics
Recent Comments